2care4 Revenue and Competitors

Claim your profile

6710 Esbjerg V, Denmark



Total Funding



Estimated Revenue & Valuation

  • 2care4's estimated annual revenue is currently $29.3M per year.(i)
  • 2care4's estimated revenue per employee is $189,329

Employee Data

  • 2care4 has 155 Employees.(i)
  • 2care4 grew their employee count by 23% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

2care4 is a European medicine company doing parallel trade and developing generics for sale in the European Union. 2care4 was established in 2005 and has through innovative thinking, teamwork and a power-to-act culture created a breathtaking fast growth through the years. 2care4 is today one of the most important parallel trading companies in Scandinavia and is doing both trading and sales all over Europe. 2care4´s headquarter is in Esbjerg, Denmark with sales offices in Sweden and Germany, and repacking facilities in Europe. 2care4 employ more than 120 highly skilled and motivated colleagues, who every day fight to supply the customers with original high quality medicine at a reduced price. The strategy is to continue a profitable growth doing what we do best! For that we need more motivated colleagues with a creative mindset - link up with this page to see our job ads or visit us at www.2care4.eu



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





2care4 News

2019-09-06 - Fortsætter eksplosiv vækst: Succesfuldt medicinalfirma får ny ...

Henrik B. Jensen (t.v.) og Toke Værndal landede i 2018 endnu et flot resultat med deres virksomhed 2care4, nemlig et overskud på omkring 21 ...

2018-10-12 - Succesfuldt medicinalfirma køber tidligere Semco-domicil

Virksomheden 2care4, som siden stiftelsen i 2005 er vokset til omkring 100 ansatte, har købt Semco Maritimes tidligere domicil i Sæddings ...

2017-03-20 - Meda recalls EpiPen batch in Denmark after reports of defects

Other firms that supply the Danish market include Orifarm and 2care4, both of which parallel import the product. Meda began selling Epipen last ...